More tools:Markets·Screener·Research·Chat

Catheter Precision, Inc. (VTAK) Financial Statements

Catheter Precision, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG0029BD0W1
XASE · usd
0.19▼ 0.02 (-8.57%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close0.21
Day's Range0.19 – 0.20
52-Week Range0.19 – 3.20
Volume640.9K
Avg Volume3.3M
Share Statistics
Shares Outstanding
Employees17
ExchangeXASE
Listed2018-09-27
Share count as of August 10, 2026
Loading Income Statement…
Key questions about Catheter Precision, Inc. (VTAK)
What is Catheter Precision, Inc.'s Market Cap?
Catheter Precision, Inc.'s Market Cap is $2.8M, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s Enterprise Value?
Catheter Precision, Inc.'s Enterprise Value is $4.0M, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s Price / Sales?
Catheter Precision, Inc.'s Price / Sales is 1.4×, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s EV / Revenue?
Catheter Precision, Inc.'s EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s EV / EBITDA?
Catheter Precision, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s Revenue (TTM)?
Catheter Precision, Inc.'s Revenue (TTM) is $1.9M, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s Net Income (TTM)?
Catheter Precision, Inc.'s Net Income (TTM) is -$13.0M, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s EBITDA?
Catheter Precision, Inc.'s EBITDA is -$17.3M, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s Diluted EPS (TTM)?
Catheter Precision, Inc.'s Diluted EPS (TTM) is -0.90, based on as-reported figures from SEC (XBRL) filings.
What is Catheter Precision, Inc.'s EBITDA Margin?
Catheter Precision, Inc.'s EBITDA Margin is -901.8%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues:
Revenues
YoY growth+380.7%+202.1%+59.7%+135.4%
Cost of revenues:
Total cost of revenues
Gross profit
% of revenue9.6%90.3%91.6%92.0%
Operating expenses
Selling, general and administrative
Research and development
Acquired in-process research and development
Total operating expenses
% of revenue397.7%626.9%4234.9%1428.8%
Operating loss
% of revenue-388.1%-536.6%-4143.3%-1336.7%
Other income (expense), net
Interest income
Interest expense
Change in fair value of royalties payable due to related parties
Change in fair value of trading debt securities—
Change in fair value of minority equity interest——
Change in fair value of deferred consideration——
Loss on debt extinguishment———
Unrealized gains and losses on marketable securities, net———
Other expenses, net
Total other income (expense), net
Loss from operations before income tax benefit
Income tax benefit
Net loss
% of revenue-324.4%-391.2%-2457.1%-1037.2%
Less: Net loss attributable to non-controlling interest
Net loss attributable to Catheter Precision, Inc.
% of revenue-323.4%-389.1%-2427.7%-996.0%
Net loss attributable to Catheter Precision, Inc. common stockholders——
Net loss per share attributable to Catheter Precision, Inc. common stockholders, basic and diluted (in dollars per share)—